ANTITHROMBOTIC ACTIVITY OF SBT-828 COMPOUND

QR Code

ANTITHROMBOTIC ACTIVITY OF SBT-828 COMPOUND

We have studied antiplatelet activity of new indole derivants on the experimental model of ADP induced aggregation of platelets in rabbit's plasma in vitro. Seven of the studied substances exceeded comparing drug of acetylsalicylic acid on EK50

Saved in:

Bibliographic Details
Main Authors:	V. S. Sirotenko, M. Туan
Format:	Article
Language:	Russian
Published:	Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2015-09-01
Series:	Фармация и фармакология (Пятигорск)
Subjects:	indole antiaggregation activity acetylsalicylic acid
Online Access:	https://www.pharmpharm.ru/jour/article/view/129
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS
by: N. A. Dmitrieva, et al.
Published: (2016-01-01)

ACETYLSALICYLIC ACID AND PREVENTION OF FATAL OUTCOMES IN CARDIOVASCULAR DISEASE: SELECTING MEDICATION FORM AND DOSE
by: O. V. Averkov
Published: (2012-08-01)

Clinical pharmacogenetics of antiaggregants: clinical pharmacologist' point of view
by: D. A. Syche, et al.
Published: (2007-08-01)

About two kinds of antithrombotic monitoring
by: Z. S. Barkagan
Published: (2003-06-01)

Zyllt in coronary atherosclerosis patients after coronary artery bypass graft surgery. Preliminary results of an open, randomized, comparative ZEUS Study
by: Y. I. Grinstein, et al.
Published: (2008-12-01)

THE SELECTION PROBLEMS OF ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION WITH COMORBIDITIES
by: N. A. Koziolova, et al.
Published: (2015-08-01)

PECULIAR PROPERTIES OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION. IS IT POSSIBLE TO DO THE TREATMENT SAFE?
by: I. V. Zotova, et al.
Published: (2016-01-01)

Antithrombotic therapy in COVID-19 patients
by: E. V. Slukhanchuk, et al.
Published: (2023-01-01)

Results of Preclinical Studies of 4-(2-(4-nitrophenyl)-2-oxoethyl)-1-(thietane-3-yl)-1H-1,2,4-triazole-4-th Bromide in Relation to the Hemostasis System <i>in vivo</i>
by: Y. Wang, et al.
Published: (2024-03-01)

Chemoreactome analysis of the antithrombotic effects of glucosamine sulfate and nonsteroidal anti-inflammatory drugs
by: O. A. Gromova, et al.
Published: (2019-03-01)

SYNTHESIS, ANTIAGGREGATION AND ANTITROMBOTIC ACTIVITIES OF NEW DERIVATIVES OF HYDROXYBENZOIC ACIDS WITH TAURIC FRAGMENT
by: A. K. Brel, et al.
Published: (2021-08-01)

Clopidogrel in cardiovascular disease treatment: modern clinical recommendations
by: I. S. Yavelov
Published: (2006-10-01)

DYNAMICS OF HEMOSTASIS AND NEUTROPHIL FUNCTIONAL ACTIVITY CHANGES IN PATIENTS WITH VARIOUS SENSITIVITY TO ACETYLSALICYLIC ACID IN ACUTE MYOCARDIAL INFARCTION
by: I. Yu. Grinshtein, et al.
Published: (2016-08-01)

Antithrombotic effect of different acetylsalicylic acid drug formulations: is there a difference?
by: A. V. Sidorov
Published: (2021-11-01)

COMBINED ACETYLSALICYLIC ACID TABLETS TECHNOLOGY
by: A. V. Simonyan, et al.
Published: (2019-01-01)

Clinical pharmacology of acetylsalicylic acid as an anti-thrombotic agent
by: V. V. Rafalsky, et al.
Published: (1970-01-01)

CLINICAL SIGNIFICANCE OF ASPIRIN RESISTANCE IN PATIENTS WITH CARDIO-VASCULAR DISEASES
by: P. J. Dovgalevsky, et al.
Published: (2016-01-01)

LONG-TERM THERAPY WITH ACETYLSALICYLIC ACID. HOW TO AVOID THE POSSIBLE COMPLICATIONS?
by: I. V. Zhirov
Published: (2016-01-01)

ON THE 125TH ANNIVERSARY OF ACETYLSALICYLIC ACID
by: I. N. Bokarev, et al.
Published: (2016-01-01)

ACETYLSALICYLIC ACID IN THE PREVENTION OF ATHEROTHROMBOTIC EVENTS
by: A. V. Govorin, et al.
Published: (2015-12-01)

Indole Derivatives Biosynthesis in Bifidobacterium longum subsp. infantis and the Tryptophan Substrate Availability
by: Shi‐Min Zhang, et al.
Published: (2025-06-01)

ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES
by: E. N. Dankovtseva
Published: (2015-09-01)

Gastrointestinal Bleeding in Antithrombotic Therapy in Patients with Coronary Heart Disease: Risk Factors, Pathogenesis and Treatment
by: N. S. Lapina, et al.
Published: (2020-07-01)

ASSAY OF ACETYLSALICYLIC ACID IN DRUG PRODUCTS BY DIFFERENTIAL SCANNING CALORIMETRY
by: A. M. Stoinova, et al.
Published: (2019-01-01)

ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL?
by: I. A. Latfullin, et al.
Published: (2016-01-01)

Synthesis of New Mannich Bases from Indole Derivatives
by: Baghdad Science Journal
Published: (2012-03-01)

Compliance as the major effectiveness determinant in preventive acetylsalicylic acid therapy
by: V. V. Rafalskiy, et al.
Published: (2011-04-01)

PREVENTION OF THROMBOSES IN ANTIPHOSPHOLIPID SYNDROME
by: Lyubov Valeryevna Kondratyeva, et al.
Published: (2009-09-01)

CHARACTERISTIC OF MECHANISMS OF ANTIULCEROGENIC ACTION OF AGENTS OF VANILLOID RECEPTORS (TRPV1) ON THE MODEL OF GASTROPATHY INDUCED BY ACETYLSALICYLIC ACID
by: F. V. Hladkykh
Published: (2017-08-01)

Induction of Antibiotic Formation of Strains of Rare Actinomycetes in Depth Cultivation
by: N. G. Kulikova, et al.
Published: (2020-05-01)

ACETYLSALICYLIC ACID: WHAT'S NEW IN THE OLD DRUG?
by: I. V. Zhirov
Published: (2015-12-01)

RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: D. H. Aynetdinova, et al.
Published: (2015-12-01)

Diffuse alveolar Hemorrhage in a patient with Behcet's: immune or nonimmune?
by: Mia Albiez, et al.
Published: (2025-06-01)

ACETYLSALICYLIC ACID: DO WE KNOW EVERYTHING ABOUT IT AND ITS PROPER USE?
by: S. A. Boldueva, et al.
Published: (2015-12-01)

Ligands of Biological and Environmental Interest as Sequestering Agents for Fe<sup>3+</sup> in Aqueous Solution: A Speciation Study of Natural Fluids
by: Anna Irto, et al.
Published: (2025-07-01)

Compliance to preventive aspirin therapy in patients after acuter myocardial infarction. ACT Study results
by: V. M. Gorbunov
Published: (2010-10-01)

Study of pharmaceutical properties of low-dosage enteric-coated acetylsalicylic acid
by: V. V. Rafalsky, et al.
Published: (2016-02-01)

Analysis of Pharmacokinetic Parameters of Acetylsalicylic Acid for Prediction of Potential Nephrotoxic Effects
by: L. M. Krasnykh, et al.
Published: (2021-12-01)

Antiplatelet drug resistance in patients with coronary heart disease
by: V. A. Sulimov, et al.
Published: (2012-12-01)

Acetylsalicylic acid as an anti-platelet agent: what forms should be used, according to evidence-based medicine?
by: O. V. Averkov
Published: (2010-04-01)